Cyclerion Therapeutics Inc (CYCN)
3.25 +0.24 (+7.97%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,057 | -5,263 | -44,078 | -51,647 | -77,802 |
| Depreciation Amortization | N/A | N/A | 65 | 472 | 2,297 |
| Accounts receivable | -556 | 96 | 4 | 27 | 1,346 |
| Accounts payable and accrued liabilities | -445 | -1,772 | 1,142 | 393 | -1,096 |
| Other Working Capital | -1,538 | -4,601 | -2,850 | 1,408 | -7,592 |
| Other Operating Activity | 1,263 | -9,705 | 5,106 | 12,830 | 10,357 |
| Operating Cash Flow | $-4,333 | $-21,245 | $-40,611 | $-36,517 | $-72,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 1,457 | 18 |
| Other Investing Activity | 0 | 10,402 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $10,402 | $N/A | $1,457 | $18 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 3,509 |
| Common Stock Issued | N/A | 24 | 29 | 282 | 331 |
| Common Stock Repurchased | N/A | 5,000 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 30,503 | 24,250 |
| Financing Cash Flow | $0 | $5,024 | $29 | $30,785 | $28,090 |
| Exchange Rate Effect | -6 | 8 | 3 | 4 | -7 |
| Beginning Cash Position | 7,571 | 13,382 | 53,961 | 58,232 | 102,621 |
| End Cash Position | 3,232 | 7,571 | 13,382 | 53,961 | 58,232 |
| Net Cash Flow | $-4,339 | $-5,811 | $-40,579 | $-4,271 | $-44,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,333 | -21,245 | -40,611 | -36,517 | -72,490 |
| Capital Expenditure | N/A | N/A | N/A | -7 | -1,524 |
| Free Cash Flow | -4,333 | -21,245 | -40,611 | -36,524 | -74,014 |